Beruflicher Werdegang

• 1977 in Münster geboren
• Studium der Betriebswirtschaftslehre an den Universitäten Bielefeld, Wien und Warwick
• 2002 Studium der Humanmedizin in Wien
• 2007 Promotion in Wien
• Tätigkeit an den Universitätskliniken von Münster, Dresden und Regensburg
• 2013 Facharzt für Radiologie in Regensburg
• 2014 Oberarzt in Regensburg
• 2016 Facharzt für Neuroradiologie in Regensburg
• 2016 Leitender Oberarzt des Instituts für Röntgendiagnostik am Universitätsklinikum Regensburg.

Als Leitender Oberarzt war Wiggermann nicht nur für den klinischen Betrieb seiner Abteilung verantwortlich, sondern setzte mit der Gründung des Zentrums für Radiologisch-Interventionelle Onkologie (RIO) am Universitätsklinikum Regensburg einen neuen Meilenstein in seinem Fachgebiet.

Prof. Dr. Wiggermann ist ein gefragter Fachreferent und -publizist. Für seine zahlreichen Veröffentlichungen wurde er bereits mehrfach ausgezeichnet.

Qualifikation

Prof. Wiggermann ist Facharzt für Radiologie und Neuroradiologie und Spezialist für Interventionelle Radiologie.

Einen besonderen Schwerpunkt seiner Arbeit stellen hierbei die onkologischen Interventionen (z.B. in Leber, Lunge, Knochen und Prostata) dar.

Fachgebiete

• Radiologie

Publikationen

Haimerl M, Probst U, Poelsterl S, Fellner C, Nickel D, Weigand K, Brunner SM, Zeman F, Stroszczynski C, Wiggermann P.
Evaluation of two-point Dixon water-fat separation for liver specific contrast-enhanced assessment of liver maximum capacity.
Sci Rep. 2018 Sep 14;8(1):13863

Fuhrmann I, Probst U, Wiggermann P, Beyer L.
Navigation Systems for Treatment Planning and Execution of Percutaneous Irreversible Electroporation.
Technol Cancer Res Treat. 2018 Jan 1;17:

Probst U, Fuhrmann I, Beyer L, Wiggermann P.
Electrochemotherapy as a New Modality in Interventional Oncology: A Review. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818785329. doi: 10.1177/1533033818785329. PubMed PMID: 29986632; PubMed Central PMCID: PMC6048674.

Haimerl M, Probst U, Poelsterl S, Beyer L, Fellner C, Selgrad M, Hornung M, Stroszczynski C, Wiggermann P. Hepatobiliary MRI: Signal intensity based assessment of liver function correlated to (13)C-Methacetin breath test. Sci Rep. 2018 Jun 13;8(1):9078. doi: 10.1038/s41598-018-27401-5. PubMed PMID: 29899400; PubMed Central PMCID: PMC5998051.

Wiesinger I, Beyer LP, Zausig N, Verloh N, Wiggermann P, Stroszczynski C, Jung EM.
Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
Clin Hemorheol Microcirc. 2018;69(1-2):59-67. doi: 10.3233/CH-189131. PubMed PMID: 29758936.

Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Dahlke M, Renner P, Seyfried T, Müller M, Stroszczynski C, Evert M, Wiggermann P.
DWI - histology: a possible means of determining degree of liver fibrosis?
Oncotarget. 2018 Apr 13;9(28):20112-20118. doi: 10.18632/oncotarget.24981. eCollection 2018 Apr 13. PubMed PMID: 29732007; PubMed Central PMCID: PMC5929450.

Beyer LP, Lürken L, Verloh N, Haimerl M, Michalik K, Schaible J, Stroszczynski C, Wiggermann P.
Stereotactically navigated percutaneous microwave ablation (MWA) compared to conventional MWA: a matched pair analysis.
Int J Comput Assist Radiol Surg. 2018 May 4. doi: 10.1007/s11548-018-1778-7. [Epub ahead of print] PubMed PMID: 29728899.

Munker S, Gerken M, Fest P, Ott C, Schnoy E, Fichtner-Feigl S, Wiggermann P, Vogelhuber M, Herr W, Stroszczynski C, Schlitt HJ, Evert M, Reng M, Klinkhammer-Schalke M, Teufel A.
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects.
BMC Cancer. 2018 Apr 23;18(1):455. doi: 10.1186/s12885-018-4380-z. PubMed PMID: 29685155; PubMed Central PMCID: PMC5913883.

Verloh N, Utpatel K, Haimerl M, Zeman F, Beyer L, Fellner C, Brennfleck F, Dahlke MH, Stroszczynski C, Evert M, Wiggermann P.
Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study.
Sci Rep. 2018 Apr 18;8(1):6207. doi: 10.1038/s41598-018-24316-z. PubMed PMID: 29670136; PubMed Central PMCID: PMC5906481.

Wiesinger I, Jung W, Zausig N, Wohlgemuth WA, Pregler B, Wiggermann P, Stroszczynski C, Jung EM.
Evaluation of dynamic effects of therapy-induced changes in microcirculation after percutaneous treatment of vascular malformations using contrast-enhanced ultrasound (CEUS) and time intensity curve (TIC) analyses.
Clin Hemorheol Microcirc. 2018;69(1-2):45-57. doi: 10.3233/CH-189118. PubMed PMID: 29630543.

Buschauer S, Koch A, Wiggermann P, Müller M, Hellerbrand C.
Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro.
Oncol Lett. 2018 Apr;15(4):4635-4640. doi: 10.3892/ol.2018.7887. Epub 2018 Jan 26. PubMed PMID: 29541235; PubMed Central PMCID: PMC5835863.

Haimerl M, Fuhrmann I, Poelsterl S, Fellner C, Nickel MD, Weigand K, Dahlke MH, Verloh N, Stroszczynski C, Wiggermann P.
Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time (13)C-methacetin breath test.
Eur Radiol. 2018 Sep;28(9):3591-3600. doi: 10.1007/s00330-018-5337-y. Epub 2018 Mar 12. PubMed PMID: 29532241.

Dollinger M, Zeman F, Müller-Wille R, Beyer LP, Stroszczynski C, Bley TA, Wiggermann P.
Presentation of Original Research at the European Congress of Radiology 2010: Frequency of Publication in Medline-Indexed Journals Within 5 Years After Presentation.
Rofo. 2018 Apr;190(4):327-333. doi: 10.1055/s-0043-123473. Epub 2018 Mar 7. PubMed PMID: 29514382.

Schicho A, Pereira PL, Michalik K, Beyer LP, Stroszczynski C, Wiggermann P.
Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies.
Onco Targets Ther. 2018 Jan 12;11:345-350. doi: 10.2147/OTT.S147852. eCollection 2018. PubMed PMID: 29391811; PubMed Central PMCID: PMC5769599.

Beyer LP, Wassermann F, Pregler B, Michalik K, Rennert J, Wiesinger I, Stroszczynski C, Wiggermann P, Jung EM.
Characterization of Focal Liver Lesions using CEUS and MRI with Liver-Specific Contrast Media: Experience of a Single Radiologic Center.
Ultraschall Med. 2017 Dec;38(6):619-625. doi: 10.1055/s-0043-105264. Epub 2017 Nov 6. PubMed PMID: 29108077.

Schicho A, Pereira PL, Haimerl M, Niessen C, Michalik K, Beyer LP, Stroszczynski C, Wiggermann P.
Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy.
Oncotarget. 2017 Aug 7;8(42):72613-72620. doi: 10.18632/oncotarget.19997. eCollection 2017 Sep 22. PubMed PMID: 29069813; PubMed Central PMCID: PMC5641156.

Wiesinger I, Wiggermann P, Zausig N, Beyer LP, Salzberger B, Stroszczynski C, Jung EM.
Percutaneous Treatment of Malignant Liver Lesions: Evaluation of Success Using Contrast- Enhanced Ultrasound (CEUS) and Perfusion Software.
Ultraschall Med. 2018 Aug;39(4):440-447. doi: 10.1055/s-0043-119353. Epub 2017 Sep 25. PubMed PMID: 28946152.

Kamusella P, Scheer F, Lüdtke CW, Wiggermann P, Wissgott C, Andresen R.
Interventional Angiography: Radiation Protection for the Examiner by using Lead-free Gloves.
J Clin Diagn Res. 2017 Jul;11(7):TC26-TC29. doi: 10.7860/JCDR/2017/25226.10305. Epub 2017 Jul 1. PubMed PMID: 28893002; PubMed Central PMCID: PMC5583900.

Bruenn K, Beyer L, Haimerl M, Pregler B, Stroszczynski C, Jung EM, Wiggermann P.
Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions.
Clin Hemorheol Microcirc. 2017;67(3-4):445-451. doi: 10.3233/CH-179225. PubMed PMID: 28885212.

Beyer LP, Pregler B, Verloh N, Brünn K, Haimerl M, Stroszczynski C, Jung EM, Wiggermann P.
Effect of irreversible electroporation of prostate cancer on microcirculation: Imaging findings in contrast-enhanced T1-weighted 3D MRI.
Clin Hemorheol Microcirc. 2017;67(3-4):399-405. doi: 10.3233/CH-179220. PubMed PMID: 28885207.

Pregler B, Beyer LP, Wiesinger I, Haimerl M, Stroszczynski C, Jung EM, Wiggermann P.
Reduced microperfusion due to portal vein thrombosis: Impact on the outcome of percutaneous thermal tumor ablation.
Clin Hemorheol Microcirc. 2017;67(3-4):383-388. doi: 10.3233/CH-179218. PubMed PMID: 28885205.

Haimerl M, Brünn K, Poelsterl S, Beyer LP, Wiesinger I, Stroszczynski C, Jung EM, Wiggermann P.
Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion.
Clin Hemorheol Microcirc. 2017;67(3-4):373-382. doi: 10.3233/CH-179217. PubMed PMID: 28885204.

Pregler B, Beyer LP, Teufel A, Niessen C, Stroszczynski C, Brodoefel H, Wiggermann P.
Low Tube Voltage Liver MDCT with Sinogram-Affirmed Iterative Reconstructions for the Detection of Hepatocellular Carcinoma.
Sci Rep. 2017 Aug 25;7(1):9460. doi: 10.1038/s41598-017-10095-6. PubMed PMID: 28842662; PubMed Central PMCID: PMC5573356.

Beyer LP, Wiggermann P.
Planning and guidance: New tools to enhance the human skills in interventional oncology.
Diagn Interv Imaging. 2017 Sep;98(9):583-588. doi: 10.1016/j.diii.2017.07.004. Epub 2017 Aug 14. Review. PubMed PMID: 28818346.

da Silva NPB, Beyer LP, Hottenrott MC, Hackl C, Schlitt HJ, Stroszczynski C, Wiggermann P, Jung EM.
Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
Clin Hemorheol Microcirc. 2017;66(4):357-368. doi: 10.3233/CH-179112. PubMed PMID: 28598835.

Schicho A, Stroszczynski C, Wiggermann P.
Emphysematous Cystitis: Mortality, Risk Factors, and Pathogens of a Rare Disease.
Clin Pract. 2017 Apr 28;7(2):930. doi: 10.4081/cp.2017.930. eCollection 2017 Apr 6. PubMed PMID: 28567236; PubMed Central PMCID: PMC5432942.

Georgieva M, Beyer L, Goecze I, Stroszczynski C, Wiggermann P, Jung EM.
Contrast-enhanced ultrasound (CEUS) in an interdisciplinary intensive care unit (ICU): Diagnostic efficacy in the assessment of post-operative complications compared to contrast-enhanced computed tomography (CECT): First results.
Clin Hemorheol Microcirc. 2017;66(4):277-282. doi: 10.3233/CH-179101. PubMed PMID: 28527198.

Wiggermann P, Brünn K, Bäumler W.
[Irreversible electroporation (IRE) : A minimally invasive therapeutic option in prostate cancer].
Radiologe. 2017 Aug;57(8):637-640. doi: 10.1007/s00117-017-0251-x. Review. German. PubMed PMID: 28477079.

Niessen C, Thumann S, Beyer L, Pregler B, Kramer J, Lang S, Teufel A, Jung EM, Stroszczynski C, Wiggermann P.
Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors.
Sci Rep. 2017 Mar 7;7:43687. doi: 10.1038/srep43687. PubMed PMID:28266600; PubMed Central PMCID: PMC5339813.

Haimerl M, Verloh N, Zeman F, Fellner C, Nickel D, Lang SA, Teufel A, Stroszczynski C, Wiggermann P.
Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry.
Sci Rep. 2017 Mar 7;7:43347. doi: 10.1038/srep43347. PubMed PMID: 28266528; PubMed Central PMCID: PMC5339723.

Schicho A, Pereira PL, Pützler M, Michalik K, Albrecht T, Nolte-Ernsting C, Stroszczynski C, Wiggermann P.
Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy.
Med Sci Monit. 2017 Feb 13;23:796-800. PubMed PMID: 28192388; PubMed Central PMCID: PMC5319442.

Haimerl M, Utpatel K, Verloh N, Zeman F, Fellner C, Nickel D, Teufel A, Fichtner-Feigl S, Evert M, Stroszczynski C, Wiggermann P.
Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis.
Sci Rep. 2017 Jan 27;7:41429. doi: 10.1038/srep41429. PubMed PMID: 28128291; PubMed Central PMCID: PMC5269752.

Schicho A, Hellerbrand C, Krüger K, Beyer LP, Wohlgemuth W, Niessen C, Hohenstein E, Stroszczynski C, Pereira PL, Wiggermann P.
Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels.
J Clin Transl Hepatol. 2016 Dec 28;4(4):288-292. doi: 10.14218/JCTH.2016.00058. Epub 2016 Dec 27. PubMed PMID: 28097096; PubMed Central PMCID: PMC5225147.

Beyer LP, Pregler B, Nießen C, Michalik K, Haimerl M, Stroszczynski C, Jung EM, Wiggermann P.
Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings during follow up.
Clin Hemorheol Microcirc. 2016;64(3):501-506. doi: 10.3233/CH-168125. PubMed PMID: 27935553.

Pregler B, Beyer LP, Wiesinger I, Nießen C, Jung EM, Stroszczynski C, Wiggermann P.
Microwave ablation of large HCC lesions: Added value of CEUS examinations for ablation success control.
Clin Hemorheol Microcirc. 2016;64(3):483-490. doi: 10.3233/CH-168113. PubMed PMID: 27935548.

Haimerl M, Poelsterl S, Beyer LP, Wiesinger I, Nießen C, Stroszczynski C, Wiggermann P, Jung EM.
Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion.
Clin Hemorheol Microcirc. 2016;64(3):435-446. doi: 10.3233/CH-168112. PubMed PMID: 27858703.

Beyer LP, Pregler B, Michalik K, Niessen C, Dollinger M, Müller M, Schlitt HJ, Stroszczynski C, Wiggermann P.
Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.
Int J Comput Assist Radiol Surg. 2017 May;12(5):803-809. doi: 10.1007/s11548-016-1485-1. Epub 2016 Sep 21. PubMed PMID: 27653615.

Beyer LP, Michalik K, Niessen C, Platz Batista da Silva N, Wiesinger I, Stroszczynski C, Wiggermann P.
Evaluation of a Robotic Assistance-System For Percutaneous Computed Tomography-Guided (CT-Guided) Facet Joint Injection: A Phantom Study.
Med Sci Monit. 2016 Sep 20;22:3334-9. PubMed PMID: 27648509; PubMed Central PMCID: PMC5042119.

Beyer LP, Pregler B, Nießen C, Schicho A, Haimerl M, Jung EM, Stroszczynski C, Wiggermann P.
Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial.
PeerJ. 2016 Aug 11;4:e2277. doi: 10.7717/peerj.2277. eCollection 2016. PubMed PMID: 27602266; PubMed Central PMCID: PMC4991851.

Scheer F, Spunar P, Wiggermann P, Wissgott C, Andresen R.
Mesenteric Panniculitis (MP) in CT - A Predictor of Malignancy?
Rofo. 2016 Oct;188(10):926-32. doi: 10.1055/s-0042-110100. Epub 2016 Aug 16. PubMed PMID: 27529397.

Niessen C, Beyer LP, Pregler B, Dollinger M, Trabold B, Schlitt HJ, Jung EM, Stroszczynski C, Wiggermann P.
Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.
J Vasc Interv Radiol. 2016 Apr;27(4):480-6. doi: 10.1016/j.jvir.2015.12.025. Epub 2016 Feb 26. PubMed PMID: 26922979.

Dollinger M, Zeman F, Niessen C, Lang SA, Beyer LP, Müller M, Stroszczynski C, Wiggermann P.
Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values.
J Vasc Interv Radiol. 2016 Jan;27(1):96-103. PubMed PMID: 26777402.

Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S, Teufel A, Stroszczynski C, Evert M, Wiggermann P.
Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation.
Sci Rep. 2015 Oct 19;5:15408. doi: 10.1038/srep15408. PubMed PMID: 26478097; PubMed Central PMCID: PMC5378898.

Haimerl M, Jung EM, Beyer LP, Pregler B, Dollinger M, Sieroń D, Niessen C, Stroszczynski C, Wiggermann P.
Chronic liver disease: Correlation of CEUS-based microperfusion and indocyanine green clearance.
Clin Hemorheol Microcirc. 2015;61(2):195-204. doi: 10.3233/CH-151990. PubMed PMID: 26410870.

Niessen C, Jung EM, Beyer L, Pregler B, Dollinger M, Haimerl M, Scheer F, Stroszczynski C, Wiggermann P.
Percutaneous irreversible electroporation (IRE) of prostate cancer: Contrast-enhanced ultrasound (CEUS) findings.
Clin Hemorheol Microcirc. 2015;61(2):135-41. doi: 10.3233/CH-151985. PubMed PMID: 26410867.

Dollinger M, Beyer LP, Haimerl M, Niessen C, Jung EM, Zeman F, Stroszczynski C, Wiggermann P.
Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
Diagn Interv Radiol. 2015 Nov-Dec;21(6):471-5. doi: 10.5152/dir.2015.14442. PubMed PMID: 26359870; PubMed Central PMCID: PMC4622394.

Dollinger M, Müller-Wille R, Zeman F, Haimerl M, Niessen C, Beyer LP, Lang SA, Teufel A, Stroszczynski C, Wiggermann P.
Correction: Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
PLoS One. 2015 Aug 28;10(8):e0137480. doi: 10.1371/journal.pone.0137480. eCollection 2015. PubMed PMID: 26317797; PubMed Central PMCID: PMC4552800.

Beyer LP, Pregler B, Niessen C, Dollinger M, Graf BM, Müller M, Schlitt HJ, Stroszczynski C, Wiggermann P.
Robot-assisted microwave thermoablation of liver tumors: a single-center experience.
Int J Comput Assist Radiol Surg. 2016 Feb;11(2):253-9. doi: 10.1007/s11548-015-1286-y. Epub 2015 Aug 26. PubMed PMID: 26307269.

Dollinger M, Müller-Wille R, Zeman F, Haimerl M, Niessen C, Beyer LP, Lang SA, Teufel A, Stroszczynski C, Wiggermann P.
Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
PLoS One. 2015 Aug 13;10(8):e0135773. doi: 10.1371/journal.pone.0135773. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0137480. PubMed PMID: 26270651; PubMed Central PMCID: PMC4535980.

Haimerl M, Schlabeck M, Verloh N, Zeman F, Fellner C, Nickel D, Barreiros AP, Loss M, Stroszczynski C, Wiggermann P.
Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry.
Eur Radiol. 2016 Apr;26(4):1125-33. doi: 10.1007/s00330-015-3919-5. Epub 2015 Jul 18. PubMed PMID: 26186960.

Niessen C, Igl J, Pregler B, Beyer L, Noeva E, Dollinger M, Schreyer AG, Jung EM, Stroszczynski C, Wiggermann P.
Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.
J Vasc Interv Radiol. 2015 May;26(5):694-702. doi: 10.1016/j.jvir.2015.02.001. Epub 2015 Mar 23. PubMed PMID: 25812712.

Verloh N, Haimerl M, Zeman F, Teufel A, Lang S, Stroszczynski C, Fellner C, Wiggermann P.
Multivariable analysis of clinical influence factors on liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI.
Rofo. 2015 Jan;187(1):29-35. doi: 10.1055/s-0034-1385211. Epub 2014 Dec 22. PubMed PMID: 25531338.

Schlecht I, Wiggermann P, Behrens G, Fischer B, Koch M, Freese J, Rubin D, Nöthlings U, Stroszczynski C, Leitzmann MF.
Reproducibility and validity of ultrasound for the measurement of visceral and subcutaneous adipose tissues.
Metabolism. 2014 Dec;63(12):1512-9. doi: 10.1016/j.metabol.2014.07.012. Epub 2014 Aug 5. PubMed PMID: 25242434.

Dornia C, Philipp A, Bauer S, Lubnow M, Müller T, Lehle K, Schmid C, Müller-Wille R, Wiggermann P, Stroszczynski C, Schreyer AG.
Analysis of thrombotic deposits in extracorporeal membrane oxygenators by multidetector computed tomography.
ASAIO J. 2014 Nov-Dec;60(6):652-6. doi: 10.1097/MAT.0000000000000133. Erratum in: ASAIO J. 2015 Mar-Apr;61(2):e13. Müller-Wille, René MüMmid [corrected to Müller-Wille, René]. PubMed PMID: 25158889.

Dollinger M, Jung EM, Beyer L, Niessen C, Scheer F, Müller-Wille R, Stroszczynski C, Wiggermann P.
Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
J Vasc Interv Radiol. 2014 Oct;25(10):1589-94. doi: 10.1016/j.jvir.2014.06.026. Epub 2014 Aug 23. PubMed PMID: 25156648.

Haimerl M, Verloh N, Fellner C, Zeman F, Teufel A, Fichtner-Feigl S, Schreyer AG, Stroszczynski C, Wiggermann P.
MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score.
Sci Rep. 2014 Jul 8;4:5621. doi: 10.1038/srep05621. PubMed PMID: 25001391; PubMed Central PMCID: PMC4085628.

Beyer LP, Pregler B, Wiesinger I, Stroszczynski C, Wiggermann P, Jung EM.
Continuous dynamic registration of microvascularization of liver tumors withcontrast-enhanced ultrasound.
Radiol Res Pract. 2014;2014:347416. doi: 10.1155/2014/347416. Epub 2014 Jun 2. PubMed PMID: 24991432; PubMed Central PMCID: PMC4060158.

Haimerl M, Wächtler M, Zeman F, Verloh N, Platzek I, Schreyer AG, Stroszczynski C, Wiggermann P.
Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.
PLoS One. 2014 Jun 20;9(6):e100315. doi: 10.1371/journal.pone.0100315. eCollection 2014. PubMed PMID: 24950259; PubMed Central PMCID: PMC4065046.

Platzek I, Sieron D, Wiggermann P, Laniado M.
Carotid Artery Stenosis: Comparison of 3D Time-of-Flight MR Angiography and Contrast-Enhanced MR Angiography at 3T.
Radiol Res Pract. 2014;2014:508715. doi: 10.1155/2014/508715. Epub 2014 Mar 23. PubMed PMID: 24778875; PubMed Central PMCID: PMC3981528.

Niessen C, Jung EM, Wohlgemuth WA, Trabold B, Haimerl M, Schreyer A, Stroszczynski C, Wiggermann P.
Response.
Korean J Radiol. 2014 Jan-Feb;15(1):182. PubMed PMID: 24665468.

Verloh N, Haimerl M, Zeman F, Schlabeck M, Barreiros A, Loss M, Schreyer AG, Stroszczynski C, Fellner C, Wiggermann P.
Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla.
Eur Radiol. 2014 May;24(5):1013-9. doi: 10.1007/s00330-014-3108-y. Epub 2014 Feb 16. PubMed PMID: 24531844.

Schleder S, Pawlik M, Wiggermann P, Ott C, Fichtner-Feigl S, Müller-Wille R, Stroszczynski C, Schreyer AG.
Interobserver agreement in mr enterography for diagnostic assessment in patients with Crohn's disease.
Rofo. 2013 Oct;185(10):992-7. PubMed PMID: 24490235.

Güntner O, Zeman F, Wohlgemuth WA, Heiss P, Jung EM, Wiggermann P, Pfister K, Stroszczynski C, Müller-Wille R.
Inferior mesenteric arterial type II endoleaks after endovascular repair of abdominal aortic aneurysm: are they predictable?
Radiology. 2014 Mar;270(3):910-9. doi: 10.1148/radiol.13130489. Epub 2013 Nov 18. PubMed PMID: 24475813.

Loibl M, Stoyanov L, Doenitz C, Brawanski A, Wiggermann P, Krutsch W, Nerlich M, Oszwald M, Neumann C, Salzberger B, Hanses F.
Outcome-related co-factors in 105 cases of vertebral osteomyelitis in a tertiary care hospital.
Infection. 2014 Jun;42(3):503-10. doi: 10.1007/s15010-013-0582-0. Epub 2014 Jan 21. PubMed PMID: 24446233.

Scheer F, Wiggermann P, Kamusella P, Wissgott C, Andresen R.
CT-assisted sympathicolysis as an additional minimally invasive therapeutic option in primary focal plantar hyperhidrosis.
Cardiovasc Intervent Radiol. 2014 Dec;37(6):1554-8. doi: 10.1007/s00270-013-0824-7. Epub 2014 Jan 16. PubMed PMID: 24430535.

Haimerl M, Verloh N, Zeman F, Fellner C, Müller-Wille R, Schreyer AG, Stroszczynski C, Wiggermann P.
Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI.
PLoS One. 2013 Dec 31;8(12):e85658. doi: 10.1371/journal.pone.0085658. eCollection 2013. PubMed PMID: 24392025; PubMed Central PMCID: PMC3877368.

Scheer F, Lüdtke CW, Kamusella P, Wiggermann P, Vieweg H, Schlöricke E, Lichtenberg M, Andresen R, Wissgott C.
Combination of rotational atherothrombectomy and Paclitaxel-coated angioplasty for femoropopliteal occlusion.
Clin Med Insights Cardiol. 2015 Apr 21;8(Suppl 2):43-8. doi: 10.4137/CMC.S15231. eCollection 2014. PubMed PMID: 25983558; PubMed Central PMCID: PMC4406303.

Niessen C, Unterpaintner E, Goessmann H, Schlitt HJ, Mueller-Schilling M, Wohlgemuth WA, Stroszczynski C, Wiggermann P.
Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
J Vasc Interv Radiol. 2014 Feb;25(2):240-7. doi: 10.1016/j.jvir.2013.10.007. Epub 2013 Nov 28. PubMed PMID: 24291001.

Haimerl M, Wächtler M, Platzek I, Müller-Wille R, Niessen C, Hoffstetter P, Schreyer AG, Stroszczynski C, Wiggermann P.
Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions.
BMC Med Imaging. 2013 Dec 1;13:41. doi: 10.1186/1471-2342-13-41. PubMed PMID: 24289722; PubMed Central PMCID: PMC3866976.

Müller-Wille R, Uller W, Gössmann H, Heiss P, Wiggermann P, Dollinger M, Kasprzak P, Pfister K, Stroszczynski C, Wohlgemuth WA.
Inferior mesenteric artery embolization before endovascular aortic aneurysm repair using amplatzer vascular plug type 4.
Cardiovasc Intervent Radiol. 2014 Aug;37(4):928-34. doi: 10.1007/s00270-013-0762-4. Epub 2013 Oct 30. PubMed PMID: 24170169.

Scheer F, Wissgott C, Lüdtke CW, Niessen C, Kamusella P, Wiggermann P, Andresen R.
Single-phase percutaneous recanalization of malignant bile duct obstructions with a covered stent graft.
Rofo. 2014 Apr;186(4):394-9. doi: 10.1055/s-0033-1355552. Epub 2013 Oct 18. PubMed PMID: 24142437.

Wiggermann P, Brünn K, Rennert J, Loss M, Wobser H, Schreyer AG, Stroszczynski C, Jung EM.
Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
Ultraschall Med. 2013 Dec;34(6):590-4. doi: 10.1055/s-0033-1355820. Epub 2013 Oct 16. PubMed PMID: 24132649.

Heibl M, Jung EM, Beyer L, Wohlgemuth WA, Stroszczynski C, Wiggermann P.
Aggregated time intensity curves after transarterial chemoembolization with degradable starch microspheres: a feasibility study.
Clin Hemorheol Microcirc. 2013 Jan 1;55(4):417-21. doi: 10.3233/CH-131779. PubMed PMID: 24113498.

Niessen C, Jung EM, Wohlgemuth WA, Trabold B, Haimerl M, Schreyer A, Stroszczynski C, Wiggermann P.
Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft.
Korean J Radiol. 2013 Sep-Oct;14(5):797-800. doi: 10.3348/kjr.2013.14.5.797. Epub 2013 Aug 30. PubMed PMID: 24043975; PubMed Central PMCID: PMC3772261.

Trabold B, Wiggermann P, Akyol D, Jung EM, Nießen C, Stroszczynski C, Graf BM, Wiese C.
Anesthesia for irreversible electroporation of hepatic malignant tumors.
J Clin Anesth. 2013 Aug;25(5):430-431. doi: 10.1016/j.jclinane.2013.03.010. Epub 2013 Aug 17. PubMed PMID: 23965203.

Niessen C, Wiggermann P, Velandia C, Stroszczynski C, Pereira PL.
Transarterial chemoembolization - status quo in Germany.
Rofo. 2013 Nov;185(11):1089-94. doi: 10.1055/s-0033-1335529. Epub 2013 Jul 29. PubMed PMID: 23897529.

Schleder S, Pawlik M, Wiggermann P, Ott C, Fichtner-Feigl S, Müller-Wille R, Stroszczynski C, Schreyer AG.
Interobserver Agreement in MR Enterography for Diagnostic Assessment in Patients with Crohn's Disease.
Rofo. 2013 Sep;184(10):992-7. doi: 10.1055/s-0033-1335445. Epub 2013 Jul 26. PubMed PMID: 23893750.

Uller W, Müller-Wille R, Loss M, Hammer S, Schleder S, Goessmann H, Wiggermann P, Stroszczynski C, Wohlgemuth WA.
Percutaneous management of postoperative bile leaks with an ethylene vinyl alcohol copolymer (Onyx).
Rofo. 2013 Dec;185(12):1182-7. doi: 10.1055/s-0033-1350153. Epub 2013 Jul 16. PubMed PMID: 23860801.

Verloh N, Haimerl M, Rennert J, Müller-Wille R, Nießen C, Kirchner G, Scherer MN, Schreyer AG, Stroszczynski C, Fellner C, Wiggermann P.
Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.
Eur J Radiol. 2013 Oct;82(10):1710-5. doi: 10.1016/j.ejrad.2013.05.033. Epub 2013 Jun 25. PubMed PMID: 23806531.

Niessen C, Jung EM, Schreyer AG, Wohlgemuth WA, Trabold B, Hahn J, Rechenmacher M, Stroszczynski C, Wiggermann P.
Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report.
J Med Case Rep. 2013 May 13;7:128. doi: 10.1186/1752-1947-7-128. PubMed PMID: 23668891; PubMed Central PMCID: PMC3657545.

Sieroń D, Wiggermann P, Knap D, Platzek I, Wawrzynek W, Stroszczynski C.
Treatment of iatrogenic IVC occlusion with implantation of a stent of a new shape dedicated to aortic aneurysms.
Pol J Radiol. 2013 Jan;78(1):75-7. doi: 10.12659/PJR.883772. PubMed PMID: 23493805; PubMed Central PMCID: PMC3596151.

Schill G, Iesalnieks I, Haimerl M, Müller-Wille R, Dendl LM, Wiggermann P, Schleder S, Rennert J, Ott C, Agha A, Stroszczynski C, Schreyer AG.
Assessment of disease behavior in patients with Crohn's disease by MR enterography.
Inflamm Bowel Dis. 2013 Apr;19(5):983-90. doi: 10.1097/MIB.0b013e31828029dd. PubMed PMID: 23474779.

Schleder S, Dendl LM, Pawlik M, Friedrich C, Ott C, Agha A, Wiggermann P, Stroszczynski C, Schreyer AG.
[MR enterography sequence evaluation for patients with Crohn's disease].
Rofo. 2013 May;185(5):440-5. doi: 10.1055/s-0032-1330516. Epub 2013 Feb 25. German. PubMed PMID: 23440646.

Kamusella P, Wissgott C, Wiggermann P, Scheer F, Andresen R.
Reduction of radiation exposure for the examiner in angiography using a direct dosimeter.
Rofo. 2013 Mar;185(3):241-6. doi: 10.1055/s-0032-1330316. Epub 2013 Feb 12. PubMed PMID: 23404429.

Müller-Wille R, Wohlgemuth WA, Heiss P, Wiggermann P, Güntner O, Schreyer AG, Hoffstetter P, Stroszczynski C, Zorger N.
Transarterial embolization of type II endoleaks after EVAR: the role of ethylene vinyl alcohol copolymer (Onyx).
Cardiovasc Intervent Radiol. 2013 Oct;36(5):1288-95. doi: 10.1007/s00270-013-0567-5. Epub 2013 Feb 9. PubMed PMID: 23397186.

Schreyer AG, Paetzel C, Fürst A, Dendl LM, Hutzel E, Müller-Wille R, Wiggermann P, Schleder S, Stroszczynski C, Hoffstetter P.
Dynamic magnetic resonance defecography in 10 asymptomatic volunteers.
World J Gastroenterol. 2012Dec 14;18(46):6836-42. doi: 10.3748/wjg.v18.i46.6836. PubMed PMID: 23239922; PubMed Central PMCID: PMC3520173.

Wiggermann P, Zeman F, Niessen C, Agha A, Trabold B, Stroszczynski C, Jung EM.
Percutaneous irreversible electroporation (IRE) of hepatic malignant tumours: contrast-enhanced ultrasound (CEUS) findings.
Clin Hemorheol Microcirc. 2012;52(2-4):417-27. doi: 10.3233/CH-2012-1615. PubMed PMID: 22986756.

Jung EM, Wiggermann P, Greis C, Eder F, Ehrich J, Jung W, Schreyer AG, Stroszczynski C, Ganzer R.
First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results.
Clin Hemorheol Microcirc. 2012;52(2-4):167-77. doi: 10.3233/CH-2012-1594. PubMed PMID: 22975940.

Mueller S, Gosau M, Wendl CM, Prantl L, Wiggermann P, Reichert TE, Jung EM.
Postoperative evaluation of microvascularization in mandibular reconstructions with microvascular flaps - first results with a new perfusion software for contrast-enhanced sonography (CEUS).
Clin Hemorheol Microcirc. 2012;52(2-4):187-96. doi: 10.3233/CH-2012-1596. PubMed PMID: 22960301.

Wiggermann P, Heibl M, Niessen C, Müller-Wille R, Gössmann H, Uller W, Poschenrieder F, Schreyer AG, Wohlgemuth WA, Stroszczynski C, Jung EM.
Degradable starch microspheres transarterial chemoembolisation (DSM-TACE) of HCC: Dynamic Contrast-Enhanced Ultrasonography (DCE-US) based evaluation of therapeutic efficacy using a novel perfusion software.
Clin Hemorheol Microcirc. 2012;52(2-4):123-9. doi: 10.3233/CH-2012-1590. PubMed PMID: 22960293.

Hoffstetter P, Hammer S, Röhrl S, Dendl LM, Dornia C, Rennert J, Müller-Wille R, Wiggermann P, Stroszczynski C, Schreyer AG.
[As time goes by--is it worth intensifying patient care during the waiting period for radiological examinations?].
Rofo. 2012 Nov;184(11):1043-8. doi: 10.1055/s-0032-1313049. Epub 2012 Jul 31. German. PubMed PMID: 22851298.

Sieroń D, Wiggermann P, Knap D, Wawrzynek W, Stroszczynski C.
Use of expanded polytetrafluoroethylen (ePTFE) stent graft in autogenic AV fistula with false aneurysm in lower extremity.
Pol J Radiol. 2012 Apr;77(2):44-6. PubMed PMID: 22844308; PubMed Central PMCID: PMC3403800.

Jung EM, Wiggermann P, Stroszczynski C, Reiser MF, Clevert DA.
[Ultrasound diagnostics of diffuse liver diseases].
Radiologe. 2012 Aug;52(8):706-16. doi:10.1007/s00117-012-2307-2. German. PubMed PMID: 22810705.

Niessen C, Jung EM, Stroszczynski C, Wiggermann P.
[Ablation of a liver metastasis with irreversible electroporation (IRE) in liver segment II adjoining the area nuda].
Rofo. 2012 Oct;184(10):937-8. Epub 2012 Jun 28. German. PubMed PMID: 22744330.

Scheer F, Wins A, Kamusella P, Wiggermann P, Wissgott C, Andresen R.
[Clinical importance of CT-assisted sympathicolysis in primary, focal plantar and palmar hyperhidrosis].
Rofo. 2012 Jul;184(7):624-8. doi: 10.1055/s-0031-1299500. Epub 2012 Jun 1. German. PubMed PMID: 22661390.

Wiggermann P, Wohlgemuth WA, Heibl M, Vasilj A, Loss M, Schreyer AG, Stroszczynski C, Jung EM.
Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.
Clin Hemorheol Microcirc. 2013;53(4):337-48. doi: 10.3233/CH-2012-1555. PubMed PMID: 22555335.

Loss M, Schneider J, Uller W, Wiggermann P, Scherer MN, Jung W, Schlitt HJ, Stroszczynski C, Jung EM.
Intraoperative high resolution linear contrast enhanced ultrasound (IOUS) for detection of microvascularization of malignant liver lesions before surgery or radiofrequeny ablation.
Clin Hemorheol Microcirc. 2012;50(1-2):65-77. doi: 10.3233/CH-2011-1444. PubMed PMID: 22538536.

Jung EM, Friedrich C, Hoffstetter P, Dendl LM, Klebl F, Agha A, Wiggermann P, Stroszcynski C, Schreyer AG.
Volume navigation with contrast enhanced ultrasound and image fusion for percutaneous interventions: first results.
PLoS One. 2012;7(3):e33956. doi: 10.1371/journal.pone.0033956. Epub 2012 Mar 20. PubMed PMID: 22448281; PubMed Central PMCID: PMC3309014.

Wiggermann P, Puls R, Vasilj A, Sieroń D, Schreyer AG, Jung EM, Wawrzynek W, Stroszczynski C.
Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival.
Med Sci Monit. 2012 Feb;18(2):CR88-92. PubMed PMID: 22293882; PubMed Central PMCID: PMC3560593.

Wiggermann P, Grützmann R, Weissenböck A, Kamusella P, Dittert DD, Stroszczynski C.
Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
Acta Radiol. 2012 Mar 1;53(2):135-9. doi: 10.1258/ar.2011.100252. Epub 2012 Jan 19. PubMed PMID: 22262868.

Wiggermann P, Jung EM, Stroszczynski C.
[Radiofrequency ablation - is a technique finished?].
Radiologe. 2012 Jan;52(1):9-14. doi: 10.1007/s00117-011-2206-y. German. PubMed PMID: 22249696.

Schreyer AG, Landfried K, Jung EM, da Silva NP, Poschenrieder F, Dornia C, Wiggermann P, Dendl LM, Holler E, Stroszczynski C, Friedrich C.
Contrast-enhanced ultrasound for differential diagnosis of suspected GvHD in patients after allogeneic transplantation.
Clin Hemorheol Microcirc. 2011;49(1-4):129-36. doi: 10.3233/CH-2011-1463. PubMed PMID: 22214684.

Uller W, Wiggermann P, Gössmann H, Klebl F, Salzberger B, Stroszczynski C, Jung EM.
Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
Clin Hemorheol Microcirc. 2011;49(1-4):55-66. doi: 10.3233/CH-2011-1457. PubMed PMID: 22214678.

Wiggermann P, Zuber-Jerger I, Zausig Y, Loss M, Scherer MN, Schreyer AG, Stroszczynski C, Jung EM.
Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Clin Hemorheol Microcirc. 2011;49(1-4):43-54. doi: 10.3233/CH-2011-1456. PubMed PMID: 22214677.

Wiggermann P, Jung EM, Glöckner S, Hoffstetter P, Uller W, Vasilj A, Schreyer A, Stroszczynski C.
Real-time elastography of hepatic thermal lesions in vitro: histopathological correlation.
Ultraschall Med. 2012 Apr;33(2):170-4. doi: 10.1055/s-0031-1281904.